Safety and efficacy of the combination of T-DM1 with radiotherapy of the central nervous system in a patient with HER2-positive metastatic breast cancer: case study and review of the literature

Approximately 35% of patients with confirmed HER2 breast cancer progress to metastases of the central nervous system (CNS). Total cerebral radiotherapy is considered as standard treatment for these cases; however, studies have shown that some chemotherapy drugs can be used during radiotherapy withou...

Descripción completa

Detalles Bibliográficos
Autores principales: Borges, Giuliano Santos, Rovere, Rodrigo Kraft, Dias, Stéphanie Mereniuk Kappel, Chong, Fernando Henrique, Morais, Mayara dos Santos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cancer Intelligence 2015
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631578/
https://www.ncbi.nlm.nih.gov/pubmed/26557884
http://dx.doi.org/10.3332/ecancer.2015.586

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631578/
https://www.ncbi.nlm.nih.gov/pubmed/26557884
http://dx.doi.org/10.3332/ecancer.2015.586

Ejemplares similares